Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹16,441 Cr
verified against source
Revenue YoY
6%
reported change
EBITDA
₹3,788 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
HUL delivered a steady Q3 FY26 with 6% revenue growth and 4% underlying volume growth, the highest in 12 quarters. Growth was broad-based across all segments, with home care gaining its highest-ever market share and beauty & well-being led by double-digit hair care growth. EBITDA margin at 23.3% remained within the guided range, while PAT before exceptional items grew 1% to INR 2,562 crore. Management cited improving macros (lower inflation, supportive RBI policy) and internal actions (quick commerce organization, portfolio transformation) as key drivers. Guidance: H2 FY26 better than H1, and FY27 better than FY26, with margins staying in the 22-23% range. Risk: volatile input costs and currency depreciation could pressure margins if pricing actions lag.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects FY27 top-line growth to exceed FY26, driven by improving macros and internal actions.
- Second half of FY26 is expected to show stronger growth than the first half, with Q3 as a normalized base.
- Consolidated EBITDA margin will remain within the guided range of 22-23% (excluding ice cream), as growth investments are prioritized.
- Calibrated price increases across portfolio, especially in home care, to offset input cost inflation.
Risks flagged
- Depreciating rupee and divergent commodity trends (palm oil, tea, crude derivatives) could pressure margins if price increases lag.
- Home care pricing has been negative for an extended period due to competitive intensity; recovery may be gradual.
- Analyst noted HUL's skincare growth is meaningfully lower than platforms like Nykaa; management attributed to portfolio breadth but did not quantify gap.
- October saw destocking due to GST 2.0 rollout; while November restocked, any future policy changes could disrupt volumes.
Key quotes
- Our UVG for the quarter is the highest UVG that we have recorded in the last twelve quarters, so this bodes well for us, and this is where we will keep focusing.
- Growth will continue to remain our number 1 priority. We will invest in the business as needed to support sustained growth, and hence we expect consolidated EBITDA margin to stay around the guided range.
- Winning in India will always require an 'and' strategy rather than an 'or' strategy.
Research modules